Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study

Table 5 Kidney disease outcomes among the 454 Tanzanian adult study participants

Variable	HIV-negative controls	HIV-infected, ART-naive	P-value versus control	HIV-infected, on ART	P-value versus control
Proportion (%)	HIV-negative controls	HIV-infected, ART-naive		HIV-infected, on ART
Median [IQR]	(number = 153)	(number = 151)		(number = 150)
Kidney disease ^a	39 (25.6%)	52 (34.4%)	0.09	62 (41.3%)	0.004
Creatinine (mmol/L)	68.3 [55.6 to 81.1]	70.9 [57.9 to 89]	0.49	64.3 [54.7 to 81.8]	0.69
eGFR	106.5 [78.8 to 119.3]	104.9 [79.9 to 116.7]	0.62	104.4 [82.1 to 115.6]	0.67
eGFR <60 mL/min	20 (13.1%)	19 (12.6%)	0.89	16 (10.7%)	0.52
Microalbuminuria	31 (20.3%)	43 (28.5%)	0.10	58 (38.7%)	0.001

^aThe primary kidney disease outcome: defined as microalbuminuria and/or eGFR <60 mL/min. ART, antiretroviral therapy; eGFR, estimated glomerular filtration rate; IQR, interquartile ratio.

ISSN: 1741-7015